Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, DHHS, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Arthritis Res Ther. 2011;13(6):R181. doi: 10.1186/ar3506. Epub 2011 Nov 1.
Although systemic autoimmune diseases (SAID) share many clinical and laboratory features, whether they also share some common features of pathogenesis remains unclear. We assessed plasma proteomic profiles among different SAID for evidence of common molecular pathways that could provide insights into pathogenic mechanisms shared by these diseases.
Differential quantitative proteomic analyses (one-dimensional reverse-phase liquid chromatography-mass spectrometry) were performed to assess patterns of plasma protein expression. Monozygotic twins (four pairs discordant for systemic lupus erythematosus, four pairs discordant for juvenile idiopathic arthritis and two pairs discordant for juvenile dermatomyositis) were studied to minimize polymorphic gene effects. Comparisons were also made to 10 unrelated, matched controls.
Multiple plasma proteins, including acute phase reactants, structural proteins, immune response proteins, coagulation and transcriptional factors, were differentially expressed similarly among the different SAID studied. Multivariate Random Forest modeling identified seven proteins whose combined altered expression levels effectively segregated affected vs. unaffected twins. Among these seven proteins, four were also identified in univariate analyses of proteomic data (syntaxin 17, α-glucosidase, paraoxonase 1, and the sixth component of complement). Molecular pathway modeling indicated that these factors may be integrated through interactions with a candidate plasma biomarker, PON1 and the pro-inflammatory cytokine IL-6.
Together, these data suggest that different SAID may share common alterations of plasma protein expression and molecular pathways. An understanding of the mechanisms leading to the altered plasma proteomes common among these SAID may provide useful insights into their pathogeneses.
尽管系统性自身免疫性疾病(SAID)具有许多临床和实验室特征,但它们是否也具有一些共同的发病机制特征尚不清楚。我们评估了不同 SAID 的血浆蛋白质组谱,以寻找共同的分子途径的证据,这些途径可能为这些疾病的发病机制提供启示。
进行差异定量蛋白质组学分析(一维反相液相色谱 - 质谱)以评估血浆蛋白表达模式。我们研究了同卵双胞胎(四对系统性红斑狼疮不一致,四对幼年特发性关节炎不一致,两对幼年皮肌炎不一致),以尽量减少多态基因的影响。还将其与 10 个无关的匹配对照进行了比较。
包括急性期反应物、结构蛋白、免疫反应蛋白、凝血和转录因子在内的多种血浆蛋白在不同的 SAID 中表现出相似的差异表达。多变量随机森林模型确定了七个蛋白质,其组合改变的表达水平有效地将受影响的双胞胎与未受影响的双胞胎分开。在这七个蛋白质中,有四个在蛋白质组学数据的单变量分析中也被识别出来(突触素 17、α-葡萄糖苷酶、对氧磷酶 1 和补体第六成分)。分子途径建模表明,这些因素可能通过与候选血浆生物标志物 PON1 和促炎细胞因子 IL-6 的相互作用进行整合。
综上所述,这些数据表明,不同的 SAID 可能具有共同的血浆蛋白质表达和分子途径的改变。了解导致这些 SAID 中常见的血浆蛋白质组改变的机制可能为它们的发病机制提供有用的见解。